Adenovirus-Vectored SARS-CoV-2 Vaccine Expressing S1-N Fusion Protein
M. S. Khan, E. Kim, A. McPherson, F. J. Weisel, S. Huang, T. W. Kenniston, E. Percivalle, I. Cassaniti, F. Baldanti, M. Meisel, A. Gambotto
This paper develops a novel adenovirus-vectored SARS-CoV-2 vaccine expressing S1-N fusion protein, showing improved immunogenicity in mice against SARS-CoV-2 variants.
bioRxiv · May 9, 2022Immunology